A Study to Evaluate Plasma and Sputum As Noninvasive Biomarkers for Bronchial Dysplasia Progression/Regression

Overview

About this study

This study is designed to determine whether or not plasma and sputum microRNA might be an effective, non-invasive biomarker for lung cancer risk.

More information

Publications

Publications are currently not available
.

Mayo Clinic Footer